Increasing rates of quetiapine overdose, misuse, and mortality in Victoria, Australia
Quetiapine is an antipsychotic available in Australia under the Pharmaceutical Benefits Scheme (PBS) for the treatment of schizophrenia, acute mania, and maintenance of bipolar disorder. Although not subsidized by the PBS, the Therapeutic Goods Administration (TGA) has also approved quetiapine use for the treatment of generalized anxiety disorder and refractory major depressive disorder (TGA, 2010). The normal therapeutic dose range for these indications is between 400 and 800 mg daily (Brett, 2015).
Source: Drug and Alcohol Dependence - Category: Addiction Authors: Julia Lee, Jennifer Pilgrim, Dimitri Gerostamoulos, Jeff Robinson, Anselm Wong Tags: Full length article Source Type: research
More News: Alcoholism | Anxiety | Australia Health | Bipolar | Depression | Generalized Anxiety Disorder (GAD) | Mania | Overdose | Schizophrenia | Seroquel